Clinical trial
Multicenter Selective Lymphadenectomy Trial II (MSLT-II)
NCT00297895 · Saint John's Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00297895 |
|---|---|
| Title | Multicenter Selective Lymphadenectomy Trial II (MSLT-II) |
| Official title | A Phase III Multicenter Randomized Trial of Sentinel Lymphadenectomy and Complete Lymph Node Dissection Versus Sentinel Lymphadenectomy Alone in Cutaneous Melanoma Patients With Molecular or Histopathological Evidence of Metastases in the Sentinel Node |
| Lead sponsor | Saint John's Cancer Institute, Other |
| Collaborators | National Institutes of Health (NIH) NIH National Cancer Institute (NCI) |
| Status | Completed |
| Study type | Interventional |
| Conditions | Melanoma |
| Intervention type | Procedure |
| Interventions | Completion Lymphadenectomy, Monitoring with nodal ultrasound |
| Enrollment | 1,939 |
| Start date | Sep 30, 2004 |
| Primary completion | Sep 30, 2019 |
| Completion | Sep 30, 2019 |
| First posted | Mar 1, 2006 |
| Last update posted | May 13, 2022 |
| Countries | Australia, Canada, Finland, Germany, Israel, Italy, Netherlands, Spain, Sweden, Switzerland, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: